Yes Fc2020 I think you are correct regarding foreign food.
But the converse of this is that this is temporary, not structural. Before coronavirus came along, Chinese had much more trust in buying foreign sourced food products: especially for their most important asset: their children.
So given this, one would assume that one day coronavirus ceases, then that demand for foreign sourced food will revert back to historical norms (I am not talking A2M specific here, I am talking general Chinese consumer preferences).
So again this plays out into my long term thesis, that one must create view points on FY23+.
If I am correct on this, and over the next year or so, the market being a voting machine in the short term, pushes down the A2M share price to $6, then this just represents long term buying opportunities. And potential to add to my position.
I am becoming more comfortable (based on current company information) to dollar average downwards from here.
I am becoming more relaxed on things.
- Forums
- ASX - By Stock
- Chart Update
Yes Fc2020 I think you are correct regarding foreign food.But...
-
- There are more pages in this discussion • 6,444 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $10.27M | 1.490M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 18844 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 41602 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11039 | 6.840 |
1 | 3000 | 6.830 |
4 | 17920 | 6.820 |
4 | 9541 | 6.810 |
2 | 5020 | 6.800 |
Price($) | Vol. | No. |
---|---|---|
6.850 | 41602 | 1 |
6.860 | 548 | 1 |
6.870 | 8050 | 3 |
6.880 | 16820 | 3 |
6.890 | 5115 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online